产品导航
产品所有类目:   催化剂>>配体>>bubblers及其他设备>>缩写>>试剂盒>>
产品中文名称:triethylphosphine(6,6,7,7,8,8,8 -七氟- 2 ,2 -甲基- 3 ,5 - octanedionate)银(Ⅰ),最小纯度 98%
产品英文名称:triethylphosphine(6,6,7,7,8,8,8-heptafluoro-2,2-dimethyl-3,5-octanedionate)silver(i), min. 98%
货号:pro_101785      产地:strem      规格/价格:询价
产品详细说明:
47-3025
Silver Triethylphosphine(6677888-heptafluoro-22-dimethyl-35-octanedionate)silver(I) min. 98%
CAS Number: 165461-74-5
MDL Number: MFCD11973810
Molecular Formula: C16H25AgF7O2P
Molecular Weight: 521.20
Chemical Formula: Ag(C3F7COCHCOC4H9)P(CH2CH3)3
Color and Form: yellow solid
Note:

SECTION 1: Product Identification
Chemical Name: Triethylphosphine(6677888-heptafluoro-22-dimethyl-35-octanedionate)
silver(I) min. 98%
Product Number: 47-3025
CAS Registry Number: 165461-74-5
Formula: Ag(C3F7COCHCOC4H9)P(CH2CH3)3
EINECS Number: None
Chemical Family: metal fluorobeta-diketonate complexes
Synonym: Triethyphosphanesilver-(I)-6677888-heptafluoro-22-dimethyl-35-octanedionate
SECTION 2: Composition and Information on Ingredients
Ingredient CAS Number Percent ACGIH (TWA) OSHA (PEL)
Title Compound 165461-74-5 100 0.01mg/m3 (Ag sl) 0.01mg/m3 (Ag sl)
SECTION 3: Hazards Identification
Emergency Overview: Irritating to eyes skin and respiratory tract. If inhaled or swallowed this compound may cause fluoride poisoning. Early symptoms include nausea vomiting diarrhea and weakness
Primary Routes of Exposure: Ingestion inhalation skin eyes
Eye Contact:
Skin Contact: Causes slight to mild irritation of the skin. Contact with the skin can lead to formation of dark blotches (silver staining)
Inhalation: Irritating to the nose mucous membranes and respiratory tract. Inhalation Dust may cause fluoride poisoning.
Ingestion: Ingestion may lead to dizziness abdominal cramps vomiting bloody diarrhea weakness convulsions and fluoride poisoning.
Acute Health Effects: Irritating to skin eyes and respiratory tract. Ingestion may lead to dizziness abdominal cramps vomiting bloody diarrhea weakness and convulsions.
Chronic Health Effects: Long term exposure to silver and silver salts can lead to a general gray pigmentation of the skin and mucous membranes. Product contains fluorine which under certain conditions maygenerate fluoride ion causing deterioration of bone kidney and liver damage.
NTP: No
IARC: No
OSHA: No
SECTION 4: First Aid Measures
Eye Exposure: Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention.
Skin Exposure: Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists.
Inhalation: Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems such as difficulty in breathing coughing wheezing or pain. In such cases seek immediate medical assistance.
Ingestion: Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel.
SECTION 5: Fire Fighting Measures
Flash Point: not applicable
Autoignition Temperature: none
Explosion Limits: none
Extinguishing Medium: none required
Special Fire Fighting Procedures: If this product is involved in a fire fire fighters should be equipped with a NIOSH approved positive pressure self- contained breathing apparatus and full protective clothing.
Hazardous Combustion and Decomposion Products: If involved in a fire this material may emit toxic fumes.
Unusual Fireor Explosion Hazards: No unusual fire or explosion hazards.
SECTION 6: Accidental Release Measures
Spill and Leak Procedures: To avoid raising dust small spills may be mixed with diatomaceous earth sand vermiculite or other suitable inert material and swept up.
SECTION 7: Handling and Storage
Handling and Storage: Store in a cool dry place in a tightly sealed container.
SECTION 8: Exposure Controls and Personal Protection
Eye Protection: Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection: Wear protective clothing and gloves.
Ventilation: Materialmay form a fine dust. If possible handle the material in an efficient fume hood.
Respirator: If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134.
Additional Protection: No additional protection required.
SECTION 9: Physical and Chemical Properties
Color and Form: white to yellow xtl.
Molecular Weight: 521.2
Melting Point: no data
Boiling Point: no data
Vapor Pressure: no data
Specific Gravity: no data
Odor: none
Solubiliy in Water: no data
SECTION 10: Stability and Reactivity
Stability: air and moisture stable
Hazardous Polymerization: no hazardous polymerization
Conditions to Avoid: none
Incompatibility: mineral acids oxidizing agents and active metals
Decomposition Products: carbon monoxide carbon dioxide carbonyl fluoride organic fumes and silver salts.
SECTION 11: Toxicological Information
RTECS Data: No information available in the RTECS files.
Carcinogenic Effects: No data
Mutagenic Effects: No data
Tetratogenic ffects: No data
SECTION 12: Ecological Information
Ecological Information: No information available
SECTION 13: Disposal Considerations
Disposal: Dispose of according to local state and federal regulations.
SECTION 14: Transportation
Shipping Name (CFR): Non-hazardous
Hazard Class (CFR): NA
Additional Hazard Class (CFR): NA
Packaging Group (CFR): NA
UN ID Number (CFR): NA
Shipping Name (IATA): Non-hazardous
Hazard Class (IATA): NA
Additional Hazard Class (IATA): NA
Packaging Group (IATA): NA
UN ID Number (IATA): NA
SECTION 15: Regulatory Information
TSCA: Not listed in the TSCA inventory.
SARA (Title 313): Title compound: See category N740 for reporting.
Second Ingredient: None
Third Ingredient: None
SECTION 16: Other Information
Disclaimer: The information herein is believed to be accurate and reliable as of the date compiled. However Strem Chemicals Inc. makes no representation warranty or guarantee of any kind with respect to the information contained in this document o any use of the product based on this information.
Preparation Date: 7/08/2009
Revision Date: 7/08/2009